These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34339007)

  • 1. Predictors of the effectiveness of insulin pumps in patients with type 1 diabetes mellitus.
    Neves JC; Neves JS; Neves C; Carvalho D
    Endocrine; 2022 Jan; 75(1):119-128. PubMed ID: 34339007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
    Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
    Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
    Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
    Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
    JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the effectiveness of long-term insulin pump therapy using a combined goal of HbA
    Quirós C; Viñals C; Giménez M; Roca D; Conget I
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Nov; 66(9):534-539. PubMed ID: 31133475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in HbA1c and Weight Following Transition to Continuous Subcutaneous Insulin Infusion Therapy in Adults With Type 1 Diabetes.
    Mehta SN; Andersen HU; Abrahamson MJ; Wolpert HA; Hommel EE; McMullen W; Ridderstråle M
    J Diabetes Sci Technol; 2017 Jan; 11(1):83-86. PubMed ID: 27402243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes.
    Halbron M; Bourron O; Andreelli F; Ciangura C; Jacqueminet S; Popelier M; Bosquet F; Rouanet S; Amouyal C; Hartemann A
    Diabetes Technol Ther; 2019 Jul; 21(7):409-412. PubMed ID: 31265349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of Insulin Regimen and Glucose Outcomes with Short-Term Real-Time Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Control on Multiple Daily Injections: The Adult DIACCOR Study.
    Picard S; Hanaire H; Reznik Y; Benhamou PY; Fendri S; Dufaitre L; Leutenegger E; Guerci B
    Diabetes Technol Ther; 2018 Jun; 20(6):403-412. PubMed ID: 29847735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the effectiveness of insulin pump therapy on glycemic control in clinical practice: a retrospective study of patients with type 1 diabetes from 10 outpatient diabetes clinics in Sweden over 5 years.
    Clements M; Matuleviciene V; Attvall S; Ekelund M; Pivodic A; Dahlqvist S; Fahlén M; Haraldsson B; Lind M
    Diabetes Technol Ther; 2015 Jan; 17(1):21-8. PubMed ID: 25470010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia.
    Hanas R; Adolfsson P
    Pediatr Diabetes; 2006 Feb; 7(1):25-31. PubMed ID: 16489971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes.
    Kallas-Koeman MM; Kong JM; Klinke JA; Butalia S; Lodha AK; Lim KI; Duan QM; Donovan LE
    Diabetologia; 2014 Apr; 57(4):681-9. PubMed ID: 24434960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with glycemic control in adult type 1 diabetes patients treated with insulin pump therapy.
    Matejko B; Skupien J; Mrozińska S; Grzanka M; Cyganek K; Kiec-Wilk B; Malecki MT; Klupa T
    Endocrine; 2015 Feb; 48(1):164-9. PubMed ID: 24798448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous insulin infusion is associated with a better glycemic control than multiple daily insulin injections without difference in diabetic ketoacidosis and hypoglycemia admissions among Emiratis with Type 1 diabetes.
    Almazrouei R; Sharma C; Afandi B; Aldahmani KM; Aburawi EH; Beshyah SA; ElGhazali G; Al Yafei Z; Al-Rifai RH; Alkaabi J
    PLoS One; 2022; 17(9):e0264545. PubMed ID: 36136973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ProAct study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systems.
    Ziegler R; Tubili C; Chico A; Guerci B; Lundberg E; Borchert M; Löffler A; Bloethner S; Weissmann J; Pfützner A
    Diabetes Technol Ther; 2013 Sep; 15(9):738-43. PubMed ID: 23931739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus Patients: Results from a Public Health System.
    Moreno-Fernandez J; Gomez FJ; Pinés P; González J; López J; López LM; Blanco B; Roa C; Herranz S; Muñoz-Rodríguez JR
    Diabetes Technol Ther; 2019 Aug; 21(8):440-447. PubMed ID: 31199682
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term efficacy of insulin pump therapy on glycemic control in adults with type 1 diabetes mellitus.
    Orr CJ; Hopman W; Yen JL; Houlden RL
    Diabetes Technol Ther; 2015 Jan; 17(1):49-54. PubMed ID: 25317602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.